Verona Pharma plc (NASDAQ: VRNA) reported Q2 EPS of ($0.01), $0.02 better than the analyst estimate of ($0.03). Revenue for the quarter came in at $0 versus the consensus estimate of $0 .

For earnings history and earnings-related data on Verona Pharma plc (VRNA) click here.